Efficacy of Kalingadi Taila Nasya in the management of Apeenasa or atrophic rhinitis

Clinical study on the efficacy of Kalingadi Taila Nasya in the management of Apeenasa w.r.t. to atrophic rhinitis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050952

Enrollment

Registered

2023-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patients having specific symptoms of Apeenasa

Exclusion criteria

Exclusion criteria: patients below 10 yrs and above 50 yrs or having any systemic disease or having nasal polyps or abnormal nasal mass are excluded

Design outcomes

Primary

Measure	Time frame
determination of effect of the interventionTimepoint: 8 weeks (about 2 months)	—

Secondary

Measure	Time frame
determination of the effect of intervention with respect to other in generalTimepoint: 8 weeks (about 2 months)	—

Countries

India

Contacts

Public ContactPradeep Kumar Prem

Health Department Government of Bihar

dr.kumariuma@yahoo.co.in9431646285

Outcome results